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Many bacterial pathogens, including pathogenic neisseriae, can use heme as an iron source for growth. To
study heme utilization by Neisseria gonorrhoeae, two heme biosynthetic mutants were constructed, one with a
mutation in hemH (the gene encoding ferrochelatase) and one with a mutation in hemA (the gene encoding
g-glutamyl tRNA reductase). The hemH mutant failed to grow without an exogenous supply of heme or
hemoglobin, whereas the hemA mutant failed to grow unless heme, hemoglobin, or heme precursors were
present. Growth of the mutants with hemoglobin required expression of the hemoglobin receptor (HpuAB) and
was TonB dependent. However, growth with heme required neither HpuAB nor TonB. An fbpA mutant grew
normally when either heme or hemoglobin was present in the medium. The heme biosynthetic mutants showed
reduced intracellular survival, compared to the parent strain, within A-431 endocervical epithelial cell cultures.
These studies demonstrate that in addition to synthesizing their own heme, N. gonorrhoeae strains are able to
internalize and utilize exogenous heme independently of FbpA but appear unable to obtain heme from within
epithelial cells for growth.
Gonorrhea, a sexually transmitted disease caused by the
human pathogen Neisseria gonorrhoeae, primarily infects co-
lumnar epithelial mucosal surfaces including the urethra, en-
docervix, rectum, and oropharynx. It is a major cause of pelvic
inflammatory disease in women and acts as a cofactor for the
spread of human immunodeficiency virus (23, 41). Gonococci
can grow within epithelial cells and are capable of invading the
epithelial barrier and disseminating via the bloodstream to
multiple sites, including the cerebrospinal fluid, skin, and joints
(32). Therefore, N. gonorrhoeae must be able to obtain nutri-
ents from a diverse range of environments.
Nearly all bacteria require iron as a nutrient for growth, and
the ability of pathogens to obtain iron from their host is a
major virulence determinant (33, 43). Gram-negative bacteria,
including N. gonorrhoeae, have evolved elaborate iron assimi-
lation systems involving outer membrane receptor proteins
that are capable of recognizing and binding different sources of
iron (19). These receptors are usually TonB dependent and are
upregulated by low intracellular levels of iron through the
repressor protein ferric uptake regulator (Fur) (2, 7, 53).
Many bacteria synthesize and secrete siderophores that che-
late iron from the environment. Receptors bind iron-contain-
ing siderophores, which are transported through the periplasm
and inner membrane by specific transporter systems (44, 47).
Gonococci are unable to synthesize siderophores but take ad-
vantage of extracellular iron transport proteins made by their
host (11). They utilize iron from human transferrin and lacto-
ferrin through the TonB-dependent receptors transferrin
binding receptor (TbpAB) and lactoferrin binding receptor
(LbpAB), respectively (5, 11).
Although soluble transport proteins and siderophores pro-
vide a means of obtaining iron for pathogens, heme remains
the largest potential source of iron from the host (38, 42).
Heme is bound in hemoproteins to form cytochromes, cata-
lase, hemoglobin (in erythrocytes), myeloperoxidase (in gran-
ulocytes), and myoglobin (in myocytes). Hemoproteins and
heme also enter the extracellular space following increased cell
turnover and breakdown, especially when inflammation and
cell damage are present (38). In addition to providing a source
of iron, heme is essential for several aerobic processes in bac-
teria (54). It acts as a cofactor for many of the cytochromes
required for oxidative phosphorylation and, in the form of
catalase, provides a defense against hydrogen peroxide, a by-
product of this process (59). Accordingly, many pathogens,
including gonococci, have retained the ability to make heme
while developing means of acquiring heme from their host.
Pathogenic neisseriae can utilize exogenous heme, hemoglo-
bin, and hemoglobin-haptoglobin as the sole iron source in
vitro (9, 30, 36, 50).
Gram-negative pathogens have adopted different strategies
for obtaining heme. Some secrete hemophores, which are anal-
ogous to siderophores but specifically bind heme or heme-
hemopexin (10, 18). Alternatively, heme or heme bound to
carrier proteins can be utilized via heme receptors, as occurs
with Yersinia spp., Plesiomonas shigelloides, Shigella dysenteriae,
Escherichia coli O157:H7, and Vibrio cholerae (12, 21, 22, 39).
Hemoglobin is a rich source of iron and heme, since there are
four heme moieties contained within a single hemoglobin mol-
ecule. Some pathogens, including Haemophilus influenzae, H.
ducreyi, N. meningitidis, and N. gonorrhoeae, have TonB-depen-
dent receptors that recognize hemoglobin (9, 16, 49).
It is unclear whether pathogenic neisseriae internalize the
heme ring intact (14, 50). One model has suggested that iron
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may be stripped from heme and transported to the inner mem-
brane by the periplasmic ferric iron binding protein (FbpA)
(14). FbpA is used to shuttle iron from transferrin and lacto-
ferrin through the periplasmic space, where it is transported to
the cytoplasm by an inner membrane permease/nucleotide
binding protein complex (FbpBC) (1, 8, 37). However, a hitA
(fbpA) nonpolar isogenic mutant of H. influenzae can still grow
with heme as the sole source of iron (26). The fbpABC genes of
N. gonorrhoeae and the analogous hitABC genes of H. influen-
zae are all located on a single operon (1, 26).
The pathways for heme synthesis in both nonplant eu-
karyotes and members of the beta and gamma subdivisions of
the Proteobacteria (e.g., E. coli) are well characterized (3). The
main difference occurs with the initial step of synthesizing
d-aminolevulinic acid (ALA). Mitochondria use succinyl coen-
zyme A and glycine as the substrates for the enzyme ALA
synthetase to make ALA, whereas members of the beta- and
gamma-Proteobacteria use g-glutamyl tRNA as substrate for
the enzyme g-glutamyl tRNA reductase (HemA) to make glu-
tamate-1-semialdehyde. Glutamate-1-semialdehyde trans-
ferase (HemL) converts glutamate-1-semialdehyde to ALA.
The remaining steps of heme synthesis are similar, including
the final step of inserting iron into the protoporphyrin IX ring
by the enzyme ferrochelatase (HemH) to make heme.
Among E. coli K-12 strains, which lack a heme receptor,
hemH isogenic mutants grow poorly because they are unable to
utilize exogenous heme or heme precursors for aerobic growth.
However, E. coli hemA isogenic mutants grow well when res-
cued by exogenous ALA, which bypasses the block in ALA
synthesis. In fact, a E. coli hemA mutant has been used suc-
cessfully as a model to demonstrate the function of heterolo-
gous heme and hemoglobin receptors, by recombinant expres-
sion, to restore growth aerobically in the presence of heme or
hemoglobin (50).
For this study, we created mutants with mutations in the
heme biosynthetic pathway (hemA and hemH) and in the
periplasmic iron transporter (fbpA). Characterization of these
mutants enabled us to determine whether exogenous heme can
be utilized as a source of both iron and heme and to better
elucidate the pathway for entry of heme. The heme mutants
were also used to determine whether intracellular heme (from
epithelial cells) could support the growth of gonococci.
MATERIALS AND METHODS
Strains, plasmids, and culture conditions. The bacterial strains and plasmids
used for this study are listed in Table 1. E. coli strains were grown at 37°C in
Luria broth (LB) medium containing appropriate antibiotics for selection. An-
tibiotics were used at the following concentrations; ampicillin, 100 mg/ml, kana-
mycin, 60 mg/ml; and spectinomycin, 80 mg/ml. Chloramphenicol was used at 30
mg/ml for E. coli and at 1 and 10 mg/ml for gonococcal strains FA1090 and MS11,
respectively.
N. gonorrhoeae was cultured at 37°C in 5% CO2 on gonococcal base (GCB)
agar medium (Difco Laboratories) containing Kellogg’s supplement I (24). Ad-
ditional heme, hemoglobin, ALA, or Kellog’s supplement II (iron nitrate) was
added where appropriate. Stock solutions of hemin (5 mg/ml) and hemoglobin
(10 mg/ml) were prepared by dissolving hemin (Sigma) in 0.1 N NaOH and
human hemoglobin (Sigma) in phosphate-buffered saline PBS (pH 7.4), respec-
tively. For iron-limiting conditions, desferrioxamine B (Desferal; Ciba-Geigy)
was added to a final concentration of 50 mM.
The growth phenotype was assessed by spreading 100 ml of a gonococcal
suspension in GCB broth, diluted 1/100 from an initial optical density at 600 nm
of 0.4, onto GCB agar (with and without desferal). Wells (0.6 cm in diameter)
were cut into the agar, and 60 ml of the following substrates were added: 2 mg of
protoporphyrin IX per ml, 25 mg of human transferrin (30% iron saturated) per
ml, 10 mM iron citrate, 10 mM iron chloride, 1 mg of heme per ml, and 10 mg
of hemoglobin per ml. All the reagents were obtained from Sigma Chemical Co.
unless otherwise stated. For growth experiments in broth, gonococcal strains
were resuspended in 10 ml of GCB broth (with and without various amounts of
TABLE 1. Strains and plasmids used in this study




FA6973 FA1090 hemH::CAT (Cmr) This study
FA6974 FA1090 hemA::V (Smr Spr) This study
FA6976 MS11 hemA::V (Smr Spr) This study
FA6977 MS11 hemH::CAT (Cmr) This study
FA6978 FA1090 fbpA::V (Smr Spr) This study
FA6979 FA1090 fbpA::aphA-3 (Kmr) This study
FA6982 FA1090 hpuA::V (Smr Spr) 9
FA7006 FA1090 tonB::V (Smr Spr) This study
FA7007 FA7006 but hemH::CAT (Cmr) This study
FA7008 FA6982 but hemH::CAT (Cmr) This study
E. coli strain
DH5aMCR Bethesda Research Laboratories
Plasmid
pCRII Vector for inserting PCR product Invitrogen Corp.
pUC18K Source for aphA-3 (Kmr) cassette 34
pHP45V Source for V (Spr Smr) cassette 45
pNC40 Source for CAT (Cmr) cassette 52
pUC9GCU Contains gonococcal uptake sequence 17
PUNCH173 Plasmid containing tonB::V 4
pUNCH1303 pCRII with hemH PCR insert This study
pUNCH1304 pUNCH1303 with CAT cassette from pNC40 This study
pUNCH1305 pCRII with hemA PCR insert This study
pUNCH1306 pUNCH1305 with V cassette from pHP45V This study
pUNCH1322 pUC9GCU with fbpA PCR insert This study
pUNCH1323 pUNCH1322 with aphA-3 cassette from pUC18K This study
pUNCH1324 pUNCH1322 with V cassette from pHP45V This study
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heme) to a Klett reading of 20 and incubated at 37°C in a shaker incubator under
5% CO2.
One consideration for characterizing a hemH mutant was that excessive
buildup of protoporphyrin IX could have a deleterious effect on its phenotype
(60). In gonococci, the potential for porphyrin toxicity may be limited if exoge-
nous heme is internalized, leading to feedback inhibition of porphyrin synthesis
by reducing the levels of HemA (58). Nevertheless, manipulations of the gono-
coccal mutants were performed with colonies less than 24 h old and under
reduced light conditions unless absolutely necessary.
PCR. The design of the hemH and hemA PCR primers was based on analysis
of sequencing contiguities released from the University of Oklahoma Gonococ-
cal Genome Sequencing Project Web site (46). Part of the hemH gene was
amplified with primers HEMH1 (59CGCAAACCGCATTACCTGAT39) and
HEMH2 (59ATTGGCTTTGGAACGATACG39). The hemA gene was ampli-
fied with primers HEMA1 (59AATCAAACCTGCCAATCCT39) and HEMA2
(59TCTTCTTCCCCCGCCTTAT39). For PCR amplification of fbpA, primers
containing incorporated restriction sites for BamHI or EcoRI (underlined) were
used: FBP1 (59CGGGATCCTATGAAAACATCTATCCGATACGCACTG39)
and FBP2 (59GGAATTCAGGCAGGGTAAGCGGCAGGGCGATCAG39).
The template for PCR was chromosomal DNA extracted from strain FA1090
(genomic DNA kit; Qiagen) (13). The PCR conditions were as follows: 94°C at
3 min for 1 cycle; 94°C for 45 s, 58°C for 45 s, and 72°C for 3 min for 30 cycles;
and 72°C for 3 min for 1 cycle. Genotypic confirmation of the plasmid constructs
and isogenic mutants was obtained by analysis of PCR products from appropriate
purified plasmid DNA (plasmid midi-prep kit; Qiagen) and phenol-chloroform
extracted chromosomal DNA (see Fig. 1 and 2).
Mutagenesis and gonococcal transformation. Plasmids containing gonococcal
DNA insert were constructed as follows (Table 1; also see Fig. 1). The hemH and
hemA PCR products were ligated into plasmid vector PCRII to generate
pUNCH 1303 and pUNCH 1305, respectively (TA cloning kit; Invitrogen). To
generate pUNCH1322, PCR-amplified DNA from fbpA and DNA from the
gonococcal uptake sequence vector pUC9GCU were double digested with
BamHI and EcoRI, gel purified, and directionally ligated (17). All the plasmids
were transformed into competent E. coli DH5a MCR cells (Bethesda Research
Laboratories), and positive clones were selected either by growth on LB ampi-
cillin medium (pUNCH1322) or by the presence of a white phenotype on iso-
propyl-b-D-thiogalactopyranoside/5-bromo-4-chloro-3-indolyl-b-D-galactopy-
ranoside (IPTG/X-Gal) LB medium containing ampicillin and kanamycin
(pUNCH1303 and pUNCH1305).
DNA cassettes containing antibiotic resistance genes were prepared as follows.
pHP45V was digested with SmaI to release a 2-kb V DNA fragment (Smr Spr),
which was isolated by gel purification (45). Similarly, a 1-kb cassette containing
the gene for chloramphenicol acetyltransferase (CAT) was isolated from pNC40
after digestion with BglII (52). A 1-kb aphA-3 (Kmr) cassette was obtained from
pUC18K by double digestion with EcoRI and BamHI followed by gel purification
(34). Both the aphA-3 and CAT fragment were treated with Klenow enzyme and
deoxynucleoside triphosphates to blunt the 59 and 39 ends.
The antibiotic resistance gene cassettes were inserted into the PCR-derived,
cloned gonococcal DNA by linearizing the plasmids as follows. pUNCH1303 was
linearized with StyI (partial digest), pUNCH1305 was linearized with HpaI, and
pUNCH1322 was linearized with StuI (see Fig. 1). Since StyI digestion did not
produce blunt ends, linearized pUNCH1303 was treated with Klenow enzyme
plus deoxynucleoside triphosphates to blunt the ends. The V cassette was ligated
to linearized pUNCH1305 and pUNCH1322 to generate pUNCH1306 and
pUNCH1324, respectively. The CAT cassette was ligated to pUNCH1303 to
generate pUNCH1304. The 1-kb aphA-3 cassette was inserted into the StuI-
digested pUNCH1322 to generate pUNCH1323. The orientation of the aphA-3
cassette was confirmed by restriction endonuclease analysis. All ligation reac-
tions were performed in the presence of T4 DNA ligase. Plasmids pUNCH1304,
pUNCH1306, pUNCH1323, and pUNCH1324 (containing the antibiotic cassette
inserts) were transformed into E. coli DH5a and selected on LB agar containing
appropriate antibiotics. The orientation and size of the cloned DNA were con-
firmed by restriction endonuclease analysis before transformation into N. gon-
orrhoeae.
The plasmids were used to transform and construct N. gonorrhoeae mutants by
allelic exchange as follows. A GCB plate containing 16 mM heme was inoculated
with a single colony of the parent strain to yield further single colonies after 24 h
of incubation. To an area circumscribed with a permanent marker and antici-
pated to contain single colonies, 10 ml of a 10 mM Tris (pH 8.5) solution
containing 1 to 2 mg of plasmid DNA was added. After 24 h of incubation, the
area containing the spotted plasmid DNA was swept with a cotton-tipped swab,
and the contents of the swab were spread on a GCB plate containing 16 mM
heme and appropriate antibiotic for selection. Transformants growing on the
antibiotic- and heme-containing medium were passed two more times onto
selective medium containing heme and stored frozen at 270°C in freezing me-
dium (20).
Transformation and antibiotic selection of plasmid DNA into strains FA1090,
MS11, and FA6982 (FA1090 hpuA::V) generated strains FA6973 (FA1090
hemH::CAT), FA6974 (FA1090 hemA::V), FA6976 (MS11 hemA::V), FA6977
(MS11 hemH::CAT), FA6978 (FA1090 fbpA::V), FA6979 (FA1090
fbpA::aphA-3), FA7006 (FA1090 tonB::V), FA7007 (FA7006 hemH::CAT), and
FA7008 (FA6982 hemH::CAT).
Southern blot analysis and preparation of hybridization probes. Phenol-chlo-
roform-extracted DNA from FA6973 (FA1090 hemH::CAT), FA6974 (FA1090
hemA::V), and FA6978 (FA1090 fbpA::V) was digested with ClaI-HincII, ClaI,
and HincII, respectively. FA1090 DNA was digested with ClaI-HincII, ClaI, or
HincII. Following electrophoresis, Southern blotting, alkali denaturation, and
prehybridization, the restriction enzyme-digested gonococcal DNA was probed
with an antibiotic cassette probe (CAT or V) or PCR-derived DNA with the
HEMA1-HEMA2, HEMH1-HEMH2, or FBP1-FBP2 primers. The antibiotic
cassette probe was labelled with the DIG High Prime kit (Boehringer Mannheim
Biochemicals), and the PCR products were labelled with the PCR DIG labelling
mix (Boehringer Mannheim).
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blots.
Western blot analysis was performed on whole-cell lysates prepared from gono-
cocci grown on GCB agar with 10 mM heme. To create iron-limiting conditions,
Desferal was added to the medium. Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis was carried out in the discontinuous buffer system of Laemmli
with a 4.5% stacking and a 12.5% resolving gel (27). Transfer and detection were
performed as described previously (55). The anti-Fbp polyclonal antibody was a
gift from T. Mietzner (University of Pittsburgh) and was used at a dilution of
1/5,000.
Intracellular growth assays. The intracellular growth assays were performed
under similar conditions to those described previously, with minor modifications
(32). Briefly, gonococcal strains MS11, FA6977 (MS11 hemH::CAT) and FA6976
(MS11 hemA::C) were grown for 16 to 18 h on GCB plates containing 10 mM
heme (35). Since phase variation may have affected the ability of gonococci to
attach to and invade cells, all the strains were passed fewer than six times and
checked for lipooligosaccharide and opacity protein (Opa) type. The lipooligo-
saccharide type was checked by analysis of silver-stained polyacrylamide gels, and
the Opa type was checked by Western blotting of transparent colonies probed
with anti-Opa monoclonal antibody 4B12 (6). A-431 cells (derived from a human
endocervical columnar epithelial line) were seeded onto 24-well plates (Falcon)
and grown to 80% confluency (5 3 105 cells/well) (32). A 250-ml volume of
Opa-negative, pilus-positive gonococci in Dulbecco’s modified Eagle’s medium
(DMEM) with 10 mg of transferrin per ml (saturation, 30%) was added to each
well at 2.5 3 106 CFU/well (multiplicity of infection, 5), and the wells were
incubated at 37°C under 5% CO2.
After 12 h of incubation, the cell culture medium was removed and replaced
for 100 min with fresh DMEM containing 10 mg of transferrin per ml and 50 mg
of gentamicin per ml. Thereafter, the cell culture medium was replaced every 2 h
with 1 ml of fresh DMEM containing 10% fetal calf serum until the wells were
ready for harvesting. Throughout the whole experiment, all the wells were
washed six times with 1 ml of phosphate-buffered saline (pH 7.4) before addition
of fresh cell culture medium, to remove any viable non-cell-associated gonococci
(32).
Intracellular bacteria were recovered by lysing the A-431 cells with 0.5 ml of
0.5% saponin in GCB broth for 15 min at 37°C. Serial 10-fold dilutions of lysate
(100 ml) were plated onto GCB agar containing 10 mM heme and incubated at
37°C under 5% CO2 for 36 to 48 h. Cell-associated counts were measured before
the addition of gentamicin, by lysing the cells with GCB containing 0.5% saponin
as above. Non-cell-associated counts were measured by pooling the cell culture
medium with 0.75 ml of fresh DMEM (used to rinse the wells once) and plating
it onto GCB agar plus 10 mM heme. Each strain was assayed in triplicate at each
time point, and all the counts were measured in duplicate.
RESULTS
The gonococcal hemH (encoding ferrochelatase) and hemA
(encoding g-glutamyl tRNA reductase) open reading frames
were identified by TBLASTN searches of the N. gonorrhoeae
FA1090 sequencing project with known HemH and HemA
sequences from E. coli (40, 46, 57). The predicted amino acid
sequence of FA1090 HemH had a size of 38 kDa with 41%
identity and 62% similarity to HemH of E. coli. Similarly, the
predicted amino acid sequence of FA1090 HemA had a size of
45 kDa with 48% identity and 65% similarity to HemA of E.
coli (40, 57). Further analysis of the FA1090 sequencing data-
base showed putative transcriptional terminator sequences lo-
cated immediately downstream of both genes, with the gene
downstream of hemH being in the opposite orientation. Fur-
thermore, none of the downstream genes appear to be involved
in heme biosynthesis. This is consistent with the arrangement
of the corresponding hemH and hemA genes in E. coli (3).
Thus, it is unlikely that interruption of hemH or hemA would
lead to a polar effect on downstream genes.
To determine if exogenous heme is internalized intact and
utilized for growth, we created gonococcal mutants with mu-
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tations in the two putative heme biosynthetic genes (hemH and
hemA) and in a periplasmic iron transporter gene (fbpA) (Fig.
1). The general strategy was to clone the open reading frames
of the genes by PCR, mutagenize them, and return the muta-
tion to the gonococcal chromosome by allelic exchange. The
insertions of the V and aphA-3 antibiotic cassettes in the fbp
operon were designed to create polar and nonpolar mutations,
respectively (34, 45). Since the hemH and hemA isogenic mu-
tants were constructed to generate a heme auxotrophic phe-
notype, gonococcal transformants were recovered by antibiotic
selection on heme-containing medium.
Confirmation that the hemH, hemA, and fbpA genes had
been successfully cloned was obtained by PCR, restriction
analysis, and Southern hybridization (Fig. 2 and data not
shown). The PCR products obtained with either the hemH,
hemA, or fbpA primers on template DNA from the isogenic
mutants were similar in size to the PCR products from the
plasmids that had transformed them, suggesting that allelic
exchange had occurred (Fig. 1 and 2). Also, the difference in
size between the PCR products from the parent strains and
their isogenic mutants were compatible with a DNA fragment,
of the length of the antibiotic cassette, being inserted into the
open reading frames of hemH, hemA, and fbpA (Fig. 1 and 2).
Full confirmation of allelic exchange was obtained by Southern
blotting with digoxigenin-labelled DNA probes of the antibi-
otic cassettes and hemH, hemA, and fbpA PCR products (data
not shown).
Growth phenotypes of the heme biosynthetic mutants. The
heme biosynthetic mutants (containing the hemA and hemH
mutations) grew on GCB agar containing 4 to 16 mM heme.
Addition of Desferal, to create iron-limiting conditions, had no
effect on growth. Interestingly, the hemH mutant turned red-
dish brown after prolonged incubation (36 to 48 h). Excessive
accumulation of heme precursors, particularly protopophyrin
IX, which could not be converted to heme in a ferrochelatase
mutant may explain this phenomenon (3). Despite the color
change, there was no obvious evidence of toxicity in the hemH
mutant. However, when more than 16 mM heme was incorpo-
rated into the agar, neither the parent strain nor the heme
mutants grew. Similarly, all strains showed a zone of inhibition
around wells containing heme in a diffusion assay (Fig. 3). A
possible explanation for the lack of growth around higher con-
centrations of heme was that sodium hydroxide (used to solu-
bilize the heme) exerted an inhibitory effect. However, growth
of the parent strains were unaffected around a control well
containing 60 ml of 0.1 M NaOH on GCB agar (data not
shown).
The hemA mutant grew well in the presence of ALA ($100
mM), provided that a source of iron was available, but grew
poorly around a well containing protoporphyrin IX (Fig. 4 and
data not shown). The hemH mutant failed to grow around wells
containing either ALA or protoporphyrin IX. Both the parent
strain and hemA mutant turned pink-red following prolonged
FIG. 1. Construction of pUNCH1304, pUNCH1306, and pUNCH1324. A single line indicates a PCR product, and a box represents either the antibiotic cassette
or plasmid vector. Only part of the plasmid vector is shown. The open reading frame (ORF) and direction of transcription for the relevant gonococcal gene, interrupted
by insertion of the antibiotic cassette, are indicated in gray. The PCR fragment for hemH contains only a portion of the hemH gene. The restriction sites used to linearize
the plasmid and insert the antibiotic cassette are shown in parentheses.
FIG. 2. Ethidium bromide-stained 0.7% agarose gel showing the PCR prod-
ucts from plasmid and gonococcal chromosomal DNA following electrophoresis.
Lanes: 1, FA1090; 2, pUNCH1304; 3, FA6973 (FA1090 hemH::CAT); 4, FA1090;
5, pUNCH1306; 6, F6974 (FA1090 hemA::V); 7, FA1090; 8, pUNCH1324; 9,
FA6978 (FA1090 fbpA::V). Oligonucleotide primers for PCR were HEMH1 and
HEMH2 for lanes 1 to 3, HEMA1 and HEMA2 for lanes 4 to 6, and FBP1 and
FBP2 for lanes 7 to 9. DNA molecular size markers are shown in kilobases.
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incubation on GCB agar with ALA. This color change may
have resulted from loss of feedback inhibition of heme synthe-
sis (56). Overproduction of heme and porphyrins can occur
with exogenous ALA, since heme synthesis is regulated by
HemA, and continues when ALA is added (58). As antici-
pated, growth of both the hemA and hemH mutants did not
occur around wells containing a nonheme iron source, consis-
tent with their dependence on a supply of exogenous heme for
growth (Fig. 3).
The hemH and hemA mutants were examined for growth
characteristics in GCB broth, both with and without additional
heme, to determine the effects of heme starvation and require-
ments for exogenous heme. The heme mutants grew very
poorly in standard GCB broth, achieving less than two dou-
blings (based on Klett readings) over a 7-h period (Fig. 5A). To
achieve growth comparable to the parent strain, the addition of
at least 1 mM heme was required (Fig. 5B). There was, how-
ever, a slight lag in the growth of the hemH mutant, compared
to the hemA mutant and the parent strain. No discernible
difference in growth rates was observed when between 1 and 16
mM heme was added to the broth (Fig. 5B and data not
shown). The MS11-derived heme mutants (FA6977 and
FA6976) showed identical growth phenotypes in the broth and
well diffusion assays to those of the FA1090-derived heme
mutants (FA6973 and FA6974) (Table 1 and data not shown).
Growth with hemoproteins as a heme source. The heme
biosynthetic mutants were tested for the ability to grow in the
presence of various hemoproteins, including hemoglobin, myo-
globin, catalase, and cytochrome c. No detectable growth oc-
curred around wells containing these heme sources, with the
exception of hemoglobin (data not shown). Growth of the
heme biosynthetic mutants with hemoglobin (.0.3 mM) as the
sole heme and iron source was comparable to growth of the
parent strain, provided that the HpuAB receptor was ex-
pressed (Fig. 3). However, after 24 h on GCB plus hemoglobin,
the colony size of the heme biosynthetic mutants was reduced
compared with that of the mutants on the same medium con-
taining Desferal (Fig. 4). The essential role of the HpuAB
receptor in the hemoglobin-utilizing biosynthetic mutants was
demonstrated by generating hemH and hemA mutants from
HpuB-expressing and -nonexpressing strains of FA1090. These
strains were tested for growth on GCB agar containing either
2.4 mM hemoglobin or 8 mM heme. Outer membranes of
colonies picked from hemoglobin plates were probed with
polyclonal antibody to HpuB on Western blots and showed the
expected 85-kDa band (data not shown) (9). Furthermore, a
double isogenic mutant containing antibiotic cassette inser-
tions in hpuA and hemH, FA7008 (FA1090 hemH::CAT
hpuA::V), grew well on GCB agar with heme after 24 h but not
on GCB agar with hemoglobin even after 48 h (9). Heme
utilization from hemoglobin was also TonB dependent, since
an HpuAB-expressing, TonB isogenic mutant, FA7007
(FA1090 hemH::CAT tonB::V), grew with heme but not with
hemoglobin (reference 4 and data not shown).
Characterization of the fbp mutants. Since heme can be
internalized and used by gonococci as an iron source for
growth, an attempt was made to construct two isogenic fbp
mutants of FA1090 and rescue them on GCB agar containing
heme or hemoglobin (1). The construction of the fbp mutants
was designed to create both a nonpolar (FA1090
fbpA::aphA-3) mutation and a polar (FA1090 fbpA::V) muta-
tion in the fbp operon (fbpABC) (34, 45).
Rescue of the fbp mutants on heme proved successful, and
(with the exception of antibiotic selection) no discernible dif-
ference in phenotype between FA6978 (FA1090 fbpA::V) and
FA6979 (FA1090 fbpA::aphA-3) was observed on further char-
acterization. The fbp mutants were unaffected in their ability to
grow on heme or hemoglobin but were unable to utilize trans-
ferrin, ferric citrate, or ferric chloride as the sole iron source
(Fig. 3). Thus, the fbp mutants were actually dependent on
FIG. 3. Growth phenotypes of FA1090, FA6973 (FA1090 hemH::CAT), FA6974 (FA1090 hemA::V), and FA6978 (FA1090 fbpA::V) around 0.6-cm wells cut in GCB
agar with 50 mM Desferral. The wells were filled with 60 ml of one of the following: heme, 1 mg/ml (Hm); hemoglobin, 10 mg/ml (Hg); transferrin, 25 mg/ml (Tf); iron
citrate, 10 mM (FeCit); and iron chloride, 10 mM (FeCl3). All the plates were incubated at 37°C for 24 h in 5% CO2.
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heme or hemoglobin for growth. Although the fbp mutants
showed a similar phenotype to the hemH mutant, requiring
similar amounts of heme or hemoglobin for growth, they did
not turn reddish brown after prolonged incubation on GCB
agar containing heme. Like the heme biosynthetic mutants,
growth with hemoglobin was dependent on expression of the
HpuAB receptor, but unlike the heme biosynthetic mutants,
the addition of Desferal to GCB-hemoglobin agar had no
observable effect on the size of the colonies at 24 h (Fig. 3 and
data not shown).
Western blots of whole-cell lysates from FA1090, probed
with a polyclonal antibody to FbpA, showed an iron-regulated
band of approximately 37 kDa, consistent with expression of
FbpA (Fig. 6). The 37-kDa band was not present in whole-cell
lysates of FA6978 (FA1090 fbpA::V) under both iron-replete
and iron-limiting conditions. However, an additional band of
about 21 and 19 kDa was present for FA6978 (FA1090
fbpA::V) and FA6979 (FA1090 fbpA::aphA-3), respectively,
which could represent N-terminal partial protein products of
FbpA (Fig. 6). The size differences can be reconciled by com-
paring the predicted size of the truncated open reading frames
from both constructs.
Heme auxotrophs fail to grow inside epithelial cells. Most
heme is found within the cytoplasm and mitochondria of cells
in the form of hemoproteins, providing a potential source of
heme and iron for growth. Since little is known about how
gonococci can utilize iron or heme from within cells, the heme
auxotrophs were tested for the ability to survive and grow
within an endocervical epithelial cell line. MS11 was chosen as
the parent strain, because it has been characterized in attach-
ment, invasion, and intraepithelial cell growth assays (32, 35).
The hemH and hemA mutants invaded cells at the same rate
as MS11 (data not shown). The ratio of cell-associated to
non-cell-associated counts for MS11 and the hemH mutant
12 h postinoculation (immediately before addition of gentami-
cin) was 46 and 37%, respectively. The intracellular counts for
MS11 and the hemH mutant 14 h after inoculation (2 h after
addition of gentamicin) were also similar: 1.3 3 104 for MS11
and 2.5 3 104 for the hemH mutant. The differences in the
ratio of cell-associated to non-cell-associated counts and in the
absolute intracellular counts were not statistically significant at
these time points. The intracellular survival of the hemH mu-
tants, however, was markedly reduced 22 h postinoculation
compared with that of MS11 (Student t test, P , 0.01) (Fig. 7).
Similarly, 12 h postinoculation, non-cell-associated bacterial
counts of the hemH mutant in cell culture medium were re-
duced more than 100-fold (Student t-test, P , 0.05) compared
with MS11 counts (data not shown). The hemA mutant gave
similar results to the hemH mutant (Fig. 7 and data not shown).
Thus, the heme biosynthetic mutants attached and invaded
A-431 cells normally but failed to grow in the cell culture
medium and showed reduced survival within A-431 epithelial
cells.
DISCUSSION
We constructed gonococcal hemA, hemH, and fbpA isogenic
mutants and confirmed their genotype by PCR and Southern
hybridization. Although a polar effect downstream of hemA
and hemH cannot be completely excluded, analysis of DNA
sequences surrounding the hemH and hemA open reading
frames released from the University of Oklahoma gonococcal
sequencing project suggests that neither of these genes form
part of an operon for heme synthesis.
The hemH mutant was predicted to lack the enzyme ferro-
chelatase, necessary for inserting iron into the porphyrin ring
of protoporphyrin IX to make heme, whereas the hemA mu-
tant was predicted to lack g-glutamyl tRNA reductase, neces-
sary for synthesis of ALA, which is an early substrate in heme
synthesis (3). The phenotypes of both mutants were consistent
with these predictions. Concern that the hemH mutant would
fail to grow, due to an inability to internalize heme, proved to
be unfounded, since the mutant grew well when either exoge-
nous heme or hemoglobin was present. The hemA mutant also
grew in the presence of ALA, provided that an iron source was
available, consistent with an inability to synthesize ALA.
Utilization of exogenous heme by gonococci is advanta-
geous, since a large proportion of the iron requirement is likely
to be directed to endogenous heme synthesis. Exogenous heme
can reduce heme biosynthesis by feedback inhibition and serve
as substrate for synthesis of hemoproteins (3, 56, 58). In addi-
tion to providing heme for synthesis of hemoproteins, exoge-
nous heme fulfills the iron requirements in gonococci. How
this occurs is unclear; eukaryotic cells contain heme oxygenase
enzymes (HO1 and HO2) which mobilize iron from heme, but
only one heme oxygenase homolog has been found in pro-
teobacteria (HmuO in Corynebacterium diphtheriae) (48).
Searches of the Oklahoma genomic sequencing and National
FIG. 4. Growth phenotypes of FA6973 (FA1090 hemH::CAT) and FA6974 (FA1090 hemA::V) around 0.6-cm wells cut in GCB agar both with and without 50 mM
Desferral (DF). The wells contain 60 ml of either 10-mg/ml hemoglobin (Hg) or 10 mM ALA. The plates were incubated at 37°C for 24 h in 5% CO2.
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Center for Biotechnology Information GeneBank databases
with HO1, HO2, and HmuO failed to show any significant
prokaryotic homology.
We demonstrated that in addition to serving as an iron
source, exogenous heme could be utilized as a heme source by
gonococci. However, excess heme inhibited growth, possibly
due to lipid peroxidation of membranes (28). The heme bio-
synthetic mutants were able to utilize heme from hemoglobin
in a TonB-dependent manner, provided that the hemoglobin
receptor (HpuAB) was expressed. Growth at 24 h with hemo-
globin as the sole heme and iron source was better than growth
on hemoglobin with additional iron in the medium, suggesting
that iron limitation enhances heme utilization from hemoglo-
bin. The most likely explanation for this observation is that
more hemoglobin receptor is expressed under iron-limiting
conditions (9). In contrast, iron limitation had no observable
effect on heme utilization from free heme, which, like iron
utilization from heme, was TonB independent (4).
There is circumstantial evidence for a gonococcal heme re-
ceptor, based on growth experiments in broth, in which a
monoclonal antibody that recognizes a 97-kDa heme affinity-
purified total membrane protein appeared to inhibit iron uti-
lization from heme (29). Characterization of a putative heme
receptor, even with an isogenic mutant, may prove difficult.
Heme is a relatively small (660-Da), poorly soluble, hydropho-
bic molecule, thereby presenting potential difficulties in differ-
entiating receptor-mediated utilization from nonspecific utili-
zation. It is quite possible that gonococci do not express a
heme receptor and that heme is internalized by nonspecific
mechanisms, such as entry through a porin protein channel.
Nonspecific uptake of heme by gonococci would account for
the apparent lack of a TonB phenotype and the lack of inhi-
FIG. 5. Growth of MS11(D), FA6976 (MS11 hemA::V) (h), and FA6977
(MS11 hemH::CAT) (E) in GCB broth with and without additional heme. (A)
Strains grown in GCB broth without heme; (B) strains grown in GCB broth with
1 to 3 mM heme. The results are based on three independent experiments, and
the vertical bars represent one standard deviation. Similar results were obtained
with FA6973 (FA1090 hemH::CAT) and FA6974 (FA1090 hemA::V), respec-
tively (data not shown).
FIG. 6. Western blot of gonococcal whole-cell lysates from FA1090, FA6978
(FA1090 fbpA::V), and FA6979 (FA1090 fbpA::aphA-3) probed with polyclonal
antibody against FbpA. Lanes: 1, FA1090 (iron replete); 2, FA1090 (iron limit-
ed); 3, FA6979 (iron replete); 4, FA6979 (iron limited); 5, FA6978 (iron replete);
6, FA6978 (iron limited).
FIG. 7. Intracellular growth and survival of MS11 (D), FA6976 (MS11
hemA::V) (h) and FA6977 (MS11 hemH::CAT) (E) inside epithelial cell line
A-431. Gentamicin was added 12 h postinoculation to allow time for attachment
and invasion. Time refers to the time after addition of gentamicin. The results
are standardized to give a ratio by dividing the number of surviving colonies
(CFUs) at various time points between 2 and 10 h after addition of the genta-
micin by the number of initial colonies (CFUi) at 2 h after addition of the
gentamicin. Thus, CFUs/CFUi at 2 h gives a ratio of 1 for all three strains.
Results are based on three independent experiments, each with three wells per
strain, and the vertical bars represent one standard deviation.
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bition of heme-dependent growth by free iron in the medium
(4, 50). The inability of gonococci to utilize iron from heme-
hemopexin and heme-albumin is also consistent with absence
of a heme receptor (15). The available evidence is insufficient
to settle the question of whether gonococci express a heme
receptor.
Complementation of a hemA E. coli mutant with a cosmid
containing meningococcal tonB, exbB, and exbD genes and a
plasmid for the meningococcal hemoglobin receptor gene
(hmbR) demonstrated growth with hemoglobin as a porphyrin
source (50). This suggests that heme is internalized in this
system. Since the E. coli outer membrane is normally imper-
vious to heme, it is unclear how heme may be internalized
through the periplasm and inner membrane into the cyto-
plasm. E. coli is not known to have a heme-specific transporter
system as occurs in Yersinia enterocolitica and Y. pestis (22, 31,
51).
Western blot analysis of the fbpA mutants showed that the
full-length product (37 kDa) was not made, but a smaller band
(about 20 kDa), which could represent a partial protein prod-
uct, was seen. However, it is unlikely that this product could
retain functional iron-binding activity, since the fbpA mutant
was unable to utilize iron from transferrin, ferric citrate, and
ferric chloride. Lactoferrin was not tested as an iron source for
the fbpA mutant because the parent strain FA1090 does not
have a complete lactoferrin receptor.
One possible route for transporting iron from heme is via
FbpA. This may occur if iron can be stripped from the heme
ring before entering the cytoplasm. Liberated iron could bind
to FbpA in the periplasm and be transported into the cyto-
plasm by the inner membrane FbpBC complex. Based on one
uptake study of 14C- and 59F-radiolabelled heme, iron ap-
peared to be stripped from heme and transported to the inner
membrane by FbpA (14). However, iron reentering the
periplasm from the cytoplasm or nonspecific binding may have
contributed to this effect. We found that FbpA was not neces-
sary for heme utilization in gonococci, because the fbpA iso-
genic mutants grew normally with heme or hemoglobin as the
sole source of iron. We cannot exclude the possibility that
FbpA plays a role in heme utilization, but it was clearly not
necessary for growth of the fbpA mutants, as it was for iron
uptake from transferrin and ferric citrate.
The gonococcal fbpA mutant phenotype was similar to that
of an H. influenzae fbpA mutant, which was unable to utilize
iron from transferrin but could still utilize iron from heme and
hemoglobin (26). Following submission of this manuscript, an
N. meningitidis fbpABC mutant which also showed a similar
phenotype to the gonococcal fbpA mutant was described (25).
This mutant grew with heme and hemoglobin as an iron source
but was unable to utilize iron from transferrin, lactoferrin, and
iron chelates.
The heme biosynthetic auxotrophs were able to attach to
and invade A-431 cells but, unlike the parent strain, failed to
survive inside the cells. No clear difference in intracellular
survival was observed between the heme biosynthetic mutants.
An inability to assimilate heme or heme precursors from within
epithelial cells seems the most likely reason for this observa-
tion. One possible explanation is that gonococci are unable to
utilize heme from hemoproteins, other than hemoglobin,
which form the largest source of intracellular heme (15, 38).
Also, many of the heme precursors and hemoproteins are
synthesized and located within mitochondria, making it diffi-
cult for gonococci to obtain these substrates for growth. It
remains unclear how gonococci acquire iron during growth
within epithelial cells.
In summary, gonococci can utilize heme and hemoglobin as
a heme source. Within epithelial cells, heme sources do not
appear able to support the survival or growth of heme auxo-
trophic mutants. Internalization of heme probably occurs in-
dependently of FbpA. Further studies to investigate and char-
acterize possible heme receptors and heme transport systems
are under way.
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